1983
DOI: 10.1093/jac/12.suppl_a.331
|View full text |Cite
|
Sign up to set email alerts
|

Ceftazidime alone and in combination in patients with cystic fibrosis: lack of efficacy in treatment of severe respiratory infections caused by Pseudomonas cepacia

Abstract: Fourteen patients with cystic fibrosis received 18 treatment courses with ceftazidime for acute respiratory illnesses associated with Pseudomonas cepacia. All patients had severe chronic lung disease. Clinical improvement occurred in only six treatment courses; eight treatment courses resulted in failure and four patients died. Severe illness was characterized by high fever, marked elevation of WBC and ESR. Treatment had no effect on sputum colony counts of Ps. cepacia in 17 of 18 courses, but significantly re… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

2
39
0
2

Year Published

1985
1985
2021
2021

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 71 publications
(43 citation statements)
references
References 0 publications
2
39
0
2
Order By: Relevance
“…Treatment of these infections is difficult as Bcc bacteria are inherently resistant to most clinically relevant antimicrobial agents (Aaron et al, 2000;Burns et al, 1996;Gold et al, 1983), including antimicrobial peptides (APs) (Loutet et al, 2006;Turner et al, 1998).…”
Section: Introductionmentioning
confidence: 99%
“…Treatment of these infections is difficult as Bcc bacteria are inherently resistant to most clinically relevant antimicrobial agents (Aaron et al, 2000;Burns et al, 1996;Gold et al, 1983), including antimicrobial peptides (APs) (Loutet et al, 2006;Turner et al, 1998).…”
Section: Introductionmentioning
confidence: 99%
“…In a noncomparative study, 14 patients colonized with P. cepacia received ceftazidime; only six demonstrated clinical improvement (7). Ceftazidime treatment did not significantly reduce sputum concentrations of the organism.…”
mentioning
confidence: 94%
“…These adverse outcomes are commonly due to cepacia syndrome, a frequently fatal, necrotizing pneumonia characterized by sepsis (17,30). Burkholderia species adapt to a wide range of environmental conditions and are intrinsically resistant to most clinically relevant antibiotics, making it very difficult to treat Bcc infections (1,5,8,15,45). Antibiotic resistance in Burkholderia has been attributed to the presence of multiple efflux pumps, antibiotic-modifying enzymes, and the structure of lipopolysaccharide (LPS) on the outer membrane, but other factors remain to be identified (18,20,37,48).…”
mentioning
confidence: 99%